Journal of Surgical Research
Volume 147, Issue 1 , Pages 41-49 , 1 June 2008

Effect of CV159–Ca2+/Calmodulin Blockade on Redox Status Hepatic Ischemia–Reperfusion Injury in Mice Evaluated by a Newly Developed In Vivo EPR Imaging Technique

  • Hiromichi P. Kobayashi, M.D.

      Affiliations

    • Department of Gastroenterological and General Surgery, St. Marianna School of Medicine, Kawasaki, Kanagawa, Japan
  • ,
  • Taiji Watanabe, Ph.D., M.D.

      Affiliations

    • Department of Gastroenterological and General Surgery, St. Marianna School of Medicine, Kawasaki, Kanagawa, Japan
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at St. Marianna School of Medicine, General Surgery, 2-16-1 Sugao Miyamaeku, Kawasaki, Kanagawa 216-8511 Japan.
  • ,
  • Shigeru Oowada, Ph.D., M.D.

      Affiliations

    • Department of Gastroenterological and General Surgery, St. Marianna School of Medicine, Kawasaki, Kanagawa, Japan
  • ,
  • Aki Hirayama, Ph.D., M.D.

      Affiliations

    • Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
  • ,
  • Sohji Nagase, Ph.D., M.D.

      Affiliations

    • Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
  • ,
  • Masato Kamibayashi, Ph.D.

      Affiliations

    • Kyoto Pharmaceutical University, Kyoto, Japan
  • ,
  • Takehito Otsubo, Ph.D., M.D.

      Affiliations

    • Department of Gastroenterological and General Surgery, St. Marianna School of Medicine, Kawasaki, Kanagawa, Japan

Received 20 March 2007

References 

  1. Rost D, Welker A, Welker J, et al. Liver-homing of purified glucorse oxidase: a novel in vivo model of physiological hepatic oxidative stress (H(2)O(2)). J Hepatol. 2006;46:482
  2. Halliwell B, Gutteridge JN. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 1990;186:1
  3. Takahashi K, Saito K, Ueda J, et al. Kinetic study on ESR signal decay of nitroxyl radicals, potent redox probes for in vivo ESR spectroscopy, caused by reactive oxygen species. Biochim Biophys Acta. 2002;1573:156
  4. Yoshida M, Saegusa Y, Fukuda A, et al. Measurement of radical-scavenging ability in hepatic metallothionein of rat using in vivo electron spin resonance spectroscopy. Toxicology. 2005;213:74
  5. Togashi H, Shinzawa H, Matsuo T. Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med. 2000;28:846
  6. Couet WR, Brasch RC, Sosnovsky C, et al. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenate. Magn Reson Imaging. 1985;3:83
  7. Hirayama A, Yoh K, Nagase S, et al. EPR imaging of reducing activity in Nrf2 transcriptional factor deficient mice. Free Radic Biol Med. 2003;34:1236
  8. Umekawa H, Yamakawa K, Nunoki K, et al. Inhibition of calmodulin function by CV159, a novel dihydropyridine compound. Biochem Pharmacol. 1988;37:3377
  9. Miyazaki H, Tanaka S, Fujii Y, et al. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV-159), on rat ischemic brain injury. Life Sci. 1999;64:869
  10. Berkel R, Egink G, Marsen TA, et al. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanism. Hypertension. 2001;37:240
  11. Ji M, Shiya K, Guo QW, et al. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2006;47:314
  12. Watanabe T, Oowada S, Kobayashi PH, et al. The role of the new Ca2+ antagonist, CV159, in hepatic IR injury—the evaluation of hepatic organ reducing activity using in vivo and ex vivo EPR. J Surg Res (in press) 2007.
  13. Kamibayashi M, Oowada S, Kameda H, et al. Synthesis and characterization of practically better DEPMPO-type spin trap, 5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide (CYPMPO). Free Radic Res. 2006;40:1166
  14. Watanabe T, Kubota S, Nagaya M, et al. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res. 2005;124:59
  15. Nedergaard J, Cannon B. Overview, preparation and properties of mitochondria from different sources. Methods Enzymol. 1979;55:3
  16. Fleischer S, Mcintyer JO, Vidal JC. Large scale preparation of rat liver mitochondria. Methods Enzymol. 1979;55:32
  17. Watanabe T, Owada S, Kobayashi PH, et al. Measurement of radical-scavenging ability in small bowel ischemia/reperfusion injury in rats using an in vivo and ex vivo electron paramagnetic resonance technique. Transplant Proc. 2007;39:253
  18. Lee M-C, Shoji H, Miyazaki H, et al. Assessment of oxidative stress in the spontaneously hypertensive rat brain using electron spin resonance (ESR) imaging and in vivo L-band ESR. Hypertens Res. 2004;27:485
  19. Miura Y, Ozawa T. Noninvasive study of radiation-induced oxidative damage using in vivo electron spin resonance. Free Radic Biol Med. 2000;28:854
  20. Hirayama A, Nagase S. Electron paramagnetic resonance imaging of oxidative stress in renal disease. Nephron Clin Pract. 2006;103:71
  21. Yamagishi S, Inagaki Y, Nakamura K, et al. A newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells though its anti-oxidative properties. J Cardiovasc Pharmacol. 2004;43:724
  22. Mason RP. Mechanism of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence. Atherosclerosis. 2002;165:191
  23. Chen L, Haught WH, Yang B, et al. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol. 1997;30:569
  24. Zhou MS, Jaimes EA, Raij L. Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens. 2004;17:167
  25. Catalioto RM, Renzetti AR, Criscuoli M, et al. Role of calcium in angiotensin II-induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells. J Cardiovasc Pharmacol. 1996;27:195
  26. Waypa GB, Marks JD, Mack MM, et al. Mitochondria reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res. 2002;91:719
  27. Hongpaisan J, Winters CA, Andrews SB. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci. 2004;24:10878
  28. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579
  29. Yellon DM. Myocardial postconditioning:reperfusion injury revisited. Am J Physiol Heart Circ Physiol. 2005;289:H3
  30. Kai S, Zhi-Su L, Quan S. Role of mitochondria in cell apotosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol. 2004;10:1934
  31. Andrew T, Derek JH, Mihaela MM, et al. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230
  32. Tissier R, Waintraub X, Couvreur N, et al. Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol. 2007;42:79

PII: S0022-4804(07)00443-X

doi: 10.1016/j.jss.2007.06.024

Journal of Surgical Research
Volume 147, Issue 1 , Pages 41-49 , 1 June 2008